| 1. |
Yannuzzi LA, Negrao S, Iida T, et al. Retinal angiomatous proliferation in age-related macular degeneration[J]. Retina, 2001, 21(5): 416-434. DOI: 10.1097/00006982-200110000-00003.
|
| 2. |
Ravera V, Bottoni F, Giani A, et al. Retinal angiomatous proliferation diagnosis: a multiimaging approach[J]. Retina, 2016, 36(12): 2274-2281. DOI: 10.1097/IAE.0000000000001152.
|
| 3. |
Lim EH, Han JI, Kim CG, et al. Characteristic findings of optical coherence tomography in retinal angiomatous proliferation[J]. Korean J Ophthalmol, 2013, 27(5): 351-360. DOI: 10.3341/kjo.2013.
|
| 4. |
胡立影, 李志清, 于荣国, 等. 特发性黄斑毛细血管扩张症的研究现状与进展[J]. 中华眼底病杂志, 2016, 32(4): 440-444. DOI: 10.3760/cma.j.issn.1005-1015.2016.04.026.Hu LY, Li ZQ, Yu RG, et al. The status and progress of studies of idiopathic parafoveal telangiectasis[J]. Chin J Ocul Fundus Dis, 2016, 32(4): 440-444. DOI: 10.3760/cma.j.issn.1005-1015.2016.04.026.
|
| 5. |
Rofagha S, Bhisitkul RB, Boyer DS, et al. Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON[J]. Ophthalmology, 2013, 120(11): 2292-2299. DOI: 10.1016/j.ophtha.2013.03.046.
|
| 6. |
Kim JM, Kim JH, Chang YS, et al. Treatment of bilateral retinal angiomatous proliferation with anti-vascular endothelial growth factor: 12-month outcome[J]. Korean J Ophthalmol, 2017, 31(3): 240-248. DOI: 10.3341/kjo.2016.0026.
|
| 7. |
Cho HJ, Lee TG, Han SY, et al. Long-term visual outcome and prognostic factors of Intravitreal anti-vascular endothelial growth factor treatment for retinal angiomatous proliferation[J]. Graefe's Arch Clin Exp Ophthalmol, 2016, 254(1): 23-30. DOI: 10.1007/s00417-015-2993-3.
|
| 8. |
Rouvas AA, Chatziralli IP, Theodossiadis PG, et al. Long-term results of intravitreal ranibizumab, intravitreal ranibizumab with photodynamic therapy, and intravitreal triamcinolone with photodynamic therapy for the treatment of retinal angiomatous proliferation[J]. Retina, 2012, 32(6): 1181-1189. DOI: 10.1097/IAE.0b013e318235d8ce.
|
| 9. |
Cho HJ, Kim HS, Yoo SG, et al. Retinal pigment epithelial tear after intravitreal ranibizumab treatment for retinal angiomatous proliferation[J]. Am J Ophthalmol, 2015, 160(5): 1000-1005. DOI: 10.1016/j.ajo.2015.07.023.
|
| 10. |
Baek J, Lee JH, Kim JY, et al. Geographic atrophy and activity of neovascularization in retinal angiomatous proliferation[J]. Invest Ophthalmol Vis Sci, 2016, 57(3): 1500-1505. DOI: 10.1167/iovs.15-18837.
|
